Finding Description
Based on record review and interview, the facility failed to ensure psychotropic medications were monitored for side effects for 5 (#7, 17, 20, 32, and #41) of 5 sampled residents who were reviewed for unnecessary medications.
The DON identified 19 residents received psychotropic medications.
Findings:
1. A physician order, dated 10/28/24, showed an order for fluoxetine (an antidepressant medication) 20 mg every day for mood disorder with depressive features.
A physician order, dated 12/10/24, showed an order for lorazepam (an antianxiety medication) 2 mg/ml give 0.25 ml at bedtime for anxiety.
A quarterly assessment, dated 02/24/25, showed Resident #7 a diagnosis of anxiety, recurrent depressive disorder, mood disorder with depressive features, and schizoaffective disorder, had a BIMS summary score of two, which indicated the resident was severely impaired in cognition for daily decision making, had received an antipsychotic medication, antianxiety medication, and an antidepressant medication.
A care plan, revised 02/27/25, read in parts, I use psychotropic medications .Monitor for side effects and effectiveness Q-SHIFT .Monitor/document/report PRN any adverse reaction of PSYCHOTROPIC medications .I have depression .Monitor/document for side effects and effectiveness .I have a dx of anxiety .Monitor/document for side effects and effectiveness.
A physician order, dated 04/04/25, showed an order for quetiapine (an antipsychotic medication) 50 mg twice daily.
A Side Effect Monitoring flowsheet, dated March 2025, read in part, BLANKS INDICATE NO SIDE EFFECTS OBSERVED. The flowsheet did not show any documentation side effects had been monitored from 03/01/25 through 03/31/25.
A Side Effect Monitoring flowsheet, dated April 2025, read in part, BLANKS INDICATE NO SIDE EFFECTS OBSERVED. The flowsheet did not show any documentation side effects had been monitored from 04/01/25 through 04/08/25.
2. A physician order, dated 10/26/24, showed an order for divalproex sodium extended release (an anticonvulsant medication) 250 mg every day for bipolar disorder.
A quarterly assessment, dated 03/03/25, showed Resident #32 had a diagnosis of depression and bipolar disorder, and a BIMS summary score of four, which indicated the resident was severely impaired in cognition for daily decision making.
A care plan, revised on 03/18/25, read in parts, I use psychotropic medications [related to] Bipolar, depression, anxiety, skin picking disorder etc .Monitor for side effects and effectiveness Q-SHIFT.
A physician order, dated 03/21/25, showed the order for divalproex sodium extended release was changed to divalproex sprinkles 250 mg every day for bipolar disorder.
A Side Effect Monitoring flowsheet, dated March 2025, read in part, BLANKS INDICATE NO SIDE EFFECTS OBSERVED. The flowsheet did not show any documentation side effects had been monitored from 03/01/25 through 03/31/25.
A Side Effect Monitoring flowsheet, dated April 2025, read in part, BLANKS INDICATE NO SIDE EFFECTS OBSERVED. The flowsheet did not show any documentation side effects had been monitored from 04/01/25 through 04/08/25.
3. A treatment administration record, dated 04/25, showed Resident #17 had diagnoses which included bipolar disorder and depression.
A physician order, dated 12/31/24, showed an order for citalopram (an antidepressant medication) 40 mg daily at bedtime for other specified persistent mood disorder.
A quarterly assessment, dated 01/07/25, showed Resident #17 had a BIMS score of 15 which was indicative of independence for daily decision making. The assessment showed Resident #17 had received an antidepressant medication.
A care plan, revised 02/22/25, read in part, I am on psychotropic medications .Monitor for side effects and effectiveness Q-SHIFT.
A Side effect Monitoring flowsheet, dated March 2025, read in part, BLANKS INDICATE NO SIDE EFFECTS OBSERVED. The flowsheet did not show any documentation side effects had been monitored from 03/01/25 through 03/31/25.
A Side effect Monitoring flowsheet, dated April 2025, read in part, BLANKS INDICATE NO SIDE EFFECTS OBSERVED. The flowsheet did not show any documentation side effects had been monitored from 04/01/25 through 04/08/25.
4. A treatment administration record, dated 04/25, showed Resident #20 had a diagnosis of major depressive disorder.
A care plan, revised 02/23/25, read in part, I am on antidepressant medication .Monitor/document for side effects and effectiveness Q-SHIFT.
A quarterly assessment, dated 03/01/25, showed Resident #20 had a BIMS score (a test for cognitive function) of 12 which was indicative of moderate impairment for daily decision making. The assessment also showed Resident #20 had received an antidepressant medication.
A physician order, dated 03/06/25, showed an order for fluoxetine (an antidepressant medication) 10 mg daily for depression.
A Side effect Monitoring flowsheet, dated March 2025, read in part, BLANKS INDICATE NO SIDE EFFECTS OBSERVED. The flowsheet did not show any documentation side effects had been monitored from 03/01/25 through 03/31/25.
A Side effect Monitoring flowsheet, dated April 2025, read in part, BLANKS INDICATE NO SIDE EFFECTS OBSERVED. The flowsheet did not show any documentation side effects had been monitored from 04/01/25 through 04/08/25.
5. A treatment administration record, dated 04/25, showed Resident #41 had diagnoses which included depression, bipolar disorder and anxiety disorder.
A physician order, dated 10/13/24, showed an order for amitriptyline (an antidepressant medication) 25 mg daily at bedtime for depression.
A physician order, dated 11/11/24, showed an order for buspirone (an antianxiety medication) 10 mg three times a day for anxiety.
A quarterly assessment, dated 12/15/24, showed Resident #41 had a BIMS score of 14 which was indicative of no impairment for daily decision making. The assessment showed Resident #41 had received an antidepressant medication and an antipsychotic medication.
A physician order, dated 02/26/25, showed an order for quetiapine fumarate (an antipsychotic medication) 25 mg daily for bipolar disorder.
A care plan, revised 02/22/25, read in part, I am on psychotropic medications .Monitor for side effects and effectiveness Q-SHIFT.
A Side effect Monitoring flowsheet, dated March 2025, read in part, BLANKS INDICATE NO SIDE EFFECTS OBSERVED. The flowsheet did not show any documentation side effects had been monitored from 03/01/25 through 03/31/25.
A Side effect Monitoring flowsheet, dated April 2025, read in part, BLANKS INDICATE NO SIDE EFFECTS OBSERVED. The flowsheet did not show any documentation side effects had been monitored from 04/01/25 through 04/08/25.
On 04/10/25 at 10:02 a.m., LPN #2 stated side effect monitoring was in the behavior book and they did not chart unless side effects were observed. LPN #2 also stated the care plan showed they should be documenting side effect monitoring every shift and they were not documenting every shift.
On 04/10/25 at 11:04 a.m., the DON stated they did not document side effect monitoring unless a side effect was noted. They also stated they were not documenting side effect monitoring every shift like the care plan requires.